REPLIMUNE

Welcome to the Brand page for “REPLIMUNE”, which is offered here for In the statement, reg. no. uk0000320659 should be deleted, and uk0003206593 should be inserted.;biological preparations in the nature of viruses for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; viruses for the treatment of cancer and tumors; viruses for inducing immune response for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceutical preparations and pharmaceutical substances for the treatment of infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceutical preparations and pharmaceutical substances used for the prevention and treatment of cancer and tumors; pharmaceuticals, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceuticals for inducing immune response for the treatment of cancer and tumors; vaccines; immunotherapy products, pharmaceuticals for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; gene therapy products, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders;pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services regarding research and development in the fields of pharmaceuticals, vaccines and medicines;.

Its status is currently believed to be active. Its class is unavailable. “REPLIMUNE” is believed to be currently owned by “Replimune Limited”.